Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 1,931


Frequency: Quarterly

pISSN 1824-4785

eISSN 1827-1936

Most read articles over the last three weeks

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):136-49
Molecular imaging of bone metastases using tumor-targeted tracers
Najme KARAMZADE-ZIARATI, Reyhaneh MANAFI-FARID, Bahar ATAEINIA, Werner LANGSTEGER, Christian PIRICH, Felix M. MOTTAGHY, Mohsen BEHESHTI *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):258-66
Major limits of dosimetrically determined activities in advanced differentiated thyroid carcinoma
Monica FINESSI *, Virginia LIBERINI, Désirée DEANDREIS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 December;63(4):355-70
CT radiomics and PET radiomics: ready for clinical implementation?
Marta BOGOWICZ *, Diem VUONG, Martin W. HUELLNER, Matea PAVIC, Nicolaus ANDRATSCHKE, Hubert S. GABRYS, Matthias GUCKENBERGER, Stephanie TANADINI-LANG

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):235-52
The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancer
Manuel WEBER, Ina BINSE, James NAGARAJAH, Andreas BOCKISCH, Ken HERRMANN, Walter JENTZEN *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):239-53
Conventional and advanced magnetic resonance imaging in patients with high-grade glioma
Whitney B. POPE *, Garth BRANDAL

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 June;64(2):143-51
Prognostic and predictive role of the tumor immune landscape
John B. HAANEN *, Christian U. BLANK

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):267-70
Advanced differentiated thyroid cancer: when to stop radioiodine?
Luca GIOVANELLA *, Douglas van NOSTRAND

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 June;64(2):162-74
The LIPI score and inflammatory biomarkers for selection of patients with solid tumors treated with checkpoint inhibitors
Jose C. BENITEZ, Gonzalo RECONDO, Elie RASSY, Laura MEZQUITA *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 December;63(4):323-38
Machine learning for radiomics-based multimodality and multiparametric modeling
Lise WEI, Sarah OSMAN, Mathieu HATT, Issam EL NAQA *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):311-20
Diffusion-weighted MRI is not superior to FDG-PET/CT for the detection of neck recurrence in well-differentiated thyroid carcinoma
Pierre VERA *, Agathe EDET-SANSON, Farzaneh QUIEFFIN, Joseph LE CLOIREC, Anne-Sophie BERTRAND, Martin CAILLEAUX, Jean-Francois MENARD, Charlotte LUSSEY-LEPOUTRE, Francoise CALLONNEC

top of page